Columbia Heart Clinic

Columbia, South Carolina 29203

0 studies enrolling now · 6 studies all time

What they study most

Angioplasty, Transluminal, Percutaneous Coronary, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Atrial Flutter, Heart Failure, Paroxysmal Atrial Fibrillation (PAF)

Studies at this site

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS) — Completed
• This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms. — Completed
• This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention — Completed